Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Bristol-Myers Squibb - Between Patent Deadlines And Revenue Shifts
Bristol-Myers Squibb - Between Patent Deadlines And Revenue Shifts
Bristol-Myers Squibb - Between Patent Deadlines And Revenue Shifts
Submitted by
admin
on October 3, 2012 - 10:50am
Source:
Seeking Alpha
News Tags:
patents
Bristol-Myers Squibb
Amylin
AstraZeneca
Novo Nordisk
Eli Lilly
Merck
Headline:
Bristol-Myers Squibb - Between Patent Deadlines And Revenue Shifts
Do Not Allow Advertisers to Use My Personal information
